Meiji Seika Pharma: Results from the Global Phase III Trial (Integral-2) of Nacubactam, a Novel β-Lactamase Inhibitor, Highlighted in The Lancet Microbe’s Coverage of ESCMID Global Congress 2026 Meiji Seika Pharma Co., Ltd. announced that results from the global Phase III…
Takeda’s Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies Takeda announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279), a next-generation, highly selective and…
Tavoron Expands Automation Capabilities with Acquisition of Fluidraulics Tavoron, a national leader in industrial automation, robotics, compressed air, motion control and engineered solutions, announced the acquisition of Fluidraulics Inc., an automation component and system distributor that has served customers across…
Charles River Provides NGS Services to Arovella Therapeutics, Accelerating Progress Toward Alternative Cancer Treatment Approaches Charles River Laboratories International, Inc. announced a collaboration with Arovella Therapeutics Ltd a biotechnology company, to provide Good Manufacturing Practice (GMP) Next Generation Sequencing (NGS)…
Arima Genomics Announces Distribution Partnership with Active Motif for Research-Specific Hi-C Sequencing Kits and Services Arima Genomics, Inc., a cancer diagnostics company bringing DNA sequence and structure together to advance cancer therapy selection, today announced a distribution partnership with…
PureTech Founded Entity Celea Therapeutics Completes $180 Million Financing to Advance Deupirfenidone as a Potential New Standard of Care to Treat Idiopathic Pulmonary Fibrosis (IPF) PureTech Health plc a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation…
Bayer Group to Consolidate U.S. Glyphosate Business Into a Distinct Entity Operating as Ruveon Bayer Group announced the consolidation of the U.S. glyphosate business into Ruveon LLC to optimize and align the business with the specific needs of the U.S.…
Pheno Therapeutics Granted FDA IND Clearance for Lead Multiple Sclerosis Therapeutic Candidate PTD802 Pheno Therapeutics Limited. (Pheno), a clinical stage biotechnology company focused on the discovery and development of small molecule therapeutics for the treatment of neurological diseases, today announced…
IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist IQM Quantum Computers, the global leader in superconducting quantum computers, announced the appointments of Dr. Craig Ciesla as Chief Technology Officer (CTO) and Dr. Inés…
Nomic and Wellcome Sanger Institute Collaborate to Bring Protein-Level Resolution to the Genetics of Immune Diversity Nomic Bio Inc. announced a research collaboration with the Wellcome Sanger Institute to perform large-scale proteomic profiling of human-derived peripheral blood mononuclear cell (PBMC)…
Pelago Bioscience acquires RG Discovery, forming an integrated drug discovery partner covering biology and chemistry Pelago Bioscience, a contract research organization (CRO) specializing in drug discovery and renowned for its cutting-edge cell target engagement assays, is pleased to announce the…
Deutsche Aircraft and Hexcel Announce Long‑Term Composite Partnership for the D328eco ® Regional Aircraft Program Deutsche Aircraft and Hexcel Corporation jointly announced the signing of a long‑term industrial partnership and supply agreement focused on advanced composite solutions for the D328eco, the next‑generation…